NaturegenicPlatform TechnologyCancerase™
Platform Technology

"Cancerase" is the world's first new concept of CRISPR anticancer drug, developed by applying gene scissors technology.
The following is our technological advantage over existing anticancer drug technology.

World’s FIRST anti-cancer drug platform using CRISPR genetic editing technology as a DNA-based anti-cancer drug

CRISPR/gRNA design to target cancer-specific mutant DNA, applicable to all solid cancers